BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Mecop - ECPv6.5.1.5//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://mecop.org
X-WR-CALDESC:Events for Mecop
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Chicago
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20200308T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20201101T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20210314T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20211107T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20220313T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20221106T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20230312T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20231105T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20240310T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20241103T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20250309T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20251102T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20260308T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20261101T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20270314T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20271107T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20280312T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20281105T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20290311T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20291104T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20300310T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20301103T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20310309T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20311102T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20320314T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20321107T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20330313T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20331106T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20340312T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20341105T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20350311T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20351104T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20360309T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20361102T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20370308T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20371101T070000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20200902T000000
DTEND;TZID=America/Chicago:20270902T000000
DTSTAMP:20260417T075624
CREATED:20200902T221953Z
LAST-MODIFIED:20260217T020031Z
UID:37951-1599004800-1819843200@mecop.org
SUMMARY:Bringing Darkness to Light: Identifying and Reporting Human Trafficking
DESCRIPTION:Define human trafficking and differentiate sex trafficking and labor trafficking.\nIdentify the risk factors that make individuals vulnerable to human trafficking.\nDiscuss potential effects that COVID-19 could have on human trafficking.\nOutline the signs of human trafficking and resources for reporting.\nDiscuss important health and referral sources for victims of trafficking\, as well as next steps for health care teams.
URL:https://mecop.org/event/bringing-darkness-to-light-identifying-and-reporting-human-trafficking/
LOCATION:Online Learning Web Portal
CATEGORIES:AMA,Human Trafficking
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20211014T000000
DTEND;TZID=America/Chicago:20261014T000000
DTSTAMP:20260417T075624
CREATED:20211014T172344Z
LAST-MODIFIED:20260408T180945Z
UID:42395-1634169600-1791936000@mecop.org
SUMMARY:Prescribing Controlled Substances: The Florida Mandated Requirement
DESCRIPTION:Outline the requirements in House Bill 21 and House Bill 451.\nDiscuss the implications of the rules outlined in HB 21 and HB 451.\nDiscuss the current opioid overdose death statistics and the effects of the Covid-19 pandemic.\nOutline current recommendations from the CDC.\nDiscuss OUD (Opioid Use Disorder) and best practices for managing and treating patients.
URL:https://mecop.org/event/prescribing-controlled-substances-the-florida-mandated-requiremen/
LOCATION:Online Learning Web Portal
CATEGORIES:AMA,Prescribing of Controlled Substances
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20211015T000000
DTEND;TZID=America/Chicago:20261015T000000
DTSTAMP:20260417T075624
CREATED:20211015T143124Z
LAST-MODIFIED:20251021T155021Z
UID:42434-1634256000-1792022400@mecop.org
SUMMARY:Point-of-Care: Claim CME for Finding Answers to Problems in Practice
DESCRIPTION:Each learner should:\nIdentify their own problem(s) in practice.\nPerform an Internet search to identify solutions to problems or questions in clinical practice.\nReview source(s) as solutions or answeres to the problem or question.\nCite the source(s) for credit.
URL:https://mecop.org/event/point-of-care-claim-cme-for-finding-answers-to-problems-in-practice/
LOCATION:Online Learning Web Portal
CATEGORIES:AMA
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20230921T000000
DTEND;TZID=America/Chicago:20260921T000000
DTSTAMP:20260417T075624
CREATED:20230921T170648Z
LAST-MODIFIED:20260408T181051Z
UID:52591-1695254400-1789948800@mecop.org
SUMMARY:Medical Errors: The Florida CME Requirement (2023)
DESCRIPTION:Discuss error prevention and risk mitigation.\nOutline important contributing factors to error.\nReview the five most misdiagnosed conditions in the state of Florida (updated 2023).\nReview legal cases from the state of Florida and discuss implications for the licensee and patient.
URL:https://mecop.org/event/medical-errors-the-florida-cme-requirement-2023-2/
LOCATION:Online Learning Web Portal
CATEGORIES:AMA,MedErrors
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20231117T000000
DTEND;TZID=America/Chicago:22031117T000000
DTSTAMP:20260417T075624
CREATED:20240105T015126Z
LAST-MODIFIED:20240105T015954Z
UID:54935-1700179200-7380374400@mecop.org
SUMMARY:Prescribing Controlled Substances
DESCRIPTION:See attachments
URL:https://mecop.org/event/prescribing-controlled-substances-5/
LOCATION:Internet Enduring Material
CATEGORIES:AMA,Prescribing of Controlled Substances
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20250805T080000
DTEND;TZID=America/Chicago:20280805T170000
DTSTAMP:20260417T075624
CREATED:20251021T163038Z
LAST-MODIFIED:20260414T143030Z
UID:65084-1754380800-1849107600@mecop.org
SUMMARY:RAISE Summit
DESCRIPTION:Explain the rationale and clinical considerations for blending calcium hydroxylapatite (CaHA) with hyaluronic acid (HA) fillers\, including rheological balance\, reversibility implications\, and safety in aesthetic applications \nApply safe injection practices in high-risk facial areas by limiting bolus volume and using anatomical landmarks to guide needle or cannula placement \nUnderstand the importance of anatomical landmarks and facial layers to ensure safe and effective injection placement with biostimulators and dermal fillers \nDifferentiate the mechanisms of action and clinical applications of CaHA and PLLA in bio-regenerative aesthetic medicine \nDescribe strategies to differentiate a medical aesthetic practice through enhanced patient experience\, comprehensive consultations\, and loyalty programs
URL:https://mecop.org/event/raise-summit/
LOCATION:Internet Enduring Material
CATEGORIES:AMA
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20260312T080000
DTEND;TZID=America/Chicago:20260312T170000
DTSTAMP:20260417T075624
CREATED:20260312T200937Z
LAST-MODIFIED:20260319T202614Z
UID:67717-1773302400-1773334800@mecop.org
SUMMARY:Risk Adjustment and Cancer-RE-MISSION is Possible
DESCRIPTION:Gain understanding of risk adjustment methodology and its role in Value Based Care models.\nReview specific official ICD-10-CM coding guidelines and how they are applied to diagnosis coding and reporting.\nIdentify elements of the medical record that help support the validation of reported conditions.\nIdentify documentation deficiencies for specific conditions.
URL:https://mecop.org/event/risk-adjustment-and-cancer-re-mission-is-possible/
LOCATION:Internet Live Webcast
CATEGORIES:AMA
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20260312T080000
DTEND;TZID=America/Chicago:20260312T170000
DTSTAMP:20260417T075624
CREATED:20260414T155723Z
LAST-MODIFIED:20260416T171629Z
UID:68153-1773302400-1773334800@mecop.org
SUMMARY:PediPlus
DESCRIPTION:Discuss the pharmacology of diabetes medications\nDiscuss the features and diagnosis of ADHD\nDiscuss the different aspects of the pediatric well exam\nDiscuss the symptoms\, diagnosis\, and treatment of Autism\nDiscuss the different parts of the newborn exam\nDiscuss screenings and testing in preventive medicine\nDiscuss the indications and pharmacology of anxiolytics and antidepressants\nDiscuss the diagnosis and treatment of obesity\nDiscuss the treatment of ADHD\nDiscuss the most common causes of infections and treatments in children\nDiscuss how to diagnose and treat hyperlipidemia\nDiscuss different strategies of talking to vaccine-hesitant patients\nDiscuss how to diagnose and treat common conditions affecting newborns\nIdentify and treat common arrhythmias\nDiscuss the pharmacology of medications used in the treatment of asthma\nDiscuss pediatric cases seen in the office\nDiscuss the pharmacology of antihypertensive medications\nDiscuss herbal medications that are taken for common medical conditions\nDiscuss diagnosis and management of osteomyelitis\nDiscuss diagnosis and management of emergent pediatric conditions\nDiscuss diagnosis and management of food allergies in the pediatric population\nDiscuss diagnosis and treatment of eosinophilic esophagitis\nDiscuss screening tests and documentation required for Medicare visits\nDiscuss diagnosis and treatment modalities of acute and chronic urticaria\nDiscuss signs and symptoms of child abuse\nDiscuss family medicine cases seen in the office\nDiscuss symptoms and treatment of common vitamin toxicities\nDiscuss signs and symptoms of dental caries\nDiscuss red flag symptoms of pediatric neoplasms\nDiscuss symptoms and treatment of gender dysphoria\nDiscuss diagnosis and treatment of hyperbilirubinemia\nDiscuss symptoms and treatment of allergic rhinitis and viral illness\nDiscuss diagnosis and treatment of bromhidrosis\nDiscussing treatment modalities of HIV\nReview patient cases
URL:https://mecop.org/event/pediplus/
LOCATION:Live Course
CATEGORIES:AMA
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20260312T080000
DTEND;TZID=America/Chicago:20260312T170000
DTSTAMP:20260417T075624
CREATED:20260414T160806Z
LAST-MODIFIED:20260414T185226Z
UID:68155-1773302400-1773334800@mecop.org
SUMMARY:FamilyPlus
DESCRIPTION:Discuss the pharmacology of diabetes medications\nDiscuss the features and diagnosis of ADHD\nDiscuss the different aspects of the pediatric well exam\nDiscuss the symptoms\, diagnosis\, and treatment of Autism\nDiscuss the different parts of the newborn exam\nDiscuss screenings and testing in preventive medicine\nDiscuss the indications and pharmacology of anxiolytics and antidepressants\nDiscuss the diagnosis and treatment of obesity\nDiscuss the treatment of ADHD\nDiscuss the most common causes of infections and treatments in children\nDiscuss how to diagnose and treat hyperlipidemia\nDiscuss different strategies of talking to vaccine-hesitant patients\nDiscuss how to diagnose and treat common conditions affecting newborns\nIdentify and treat common arrhythmias\nDiscuss the pharmacology of medications used in the treatment of asthma\nDiscuss pediatric cases seen in the office\nDiscuss the pharmacology of antihypertensive medications\nDiscuss herbal medications that are taken for common medical conditions\nDiscuss diagnosis and management of osteomyelitis\nDiscuss diagnosis and management of emergent pediatric conditions\nDiscuss diagnosis and management of food allergies in the pediatric population\nDiscuss diagnosis and treatment of eosinophilic esophagitis\nDiscuss screening tests and documentation required for Medicare visits\nDiscuss diagnosis and treatment modalities of acute and chronic urticaria\nDiscuss signs and symptoms of child abuse\nDiscuss family medicine cases seen in the office\nDiscuss symptoms and treatment of common vitamin toxicities\nDiscuss signs and symptoms of dental caries\nDiscuss red flag symptoms of pediatric neoplasms\nDiscuss symptoms and treatment of gender dysphoria\nDiscuss diagnosis and treatment of hyperbilirubinemia\nDiscuss symptoms and treatment of allergic rhinitis and viral illness\nDiscuss diagnosis and treatment of bromhidrosis\nDiscussing treatment modalities of HIV\nReview patient casesDiscuss the pharmacology of diabetes medications\nDiscuss the features and diagnosis of ADHD\nDiscuss the different aspects of the pediatric well exam\nDiscuss the symptoms\, diagnosis\, and treatment of Autism\nDiscuss the different parts of the newborn exam\nDiscuss screenings and testing in preventive medicine\nDiscuss the indications and pharmacology of anxiolytics and antidepressants\nDiscuss the diagnosis and treatment of obesity\nDiscuss the treatment of ADHD\nDiscuss the most common causes of infections and treatments in children\nDiscuss how to diagnose and treat hyperlipidemia\nDiscuss different strategies of talking to vaccine-hesitant patients\nDiscuss how to diagnose and treat common conditions affecting newborns\nIdentify and treat common arrhythmias\nDiscuss the pharmacology of medications used in the treatment of asthma\nDiscuss pediatric cases seen in the office\nDiscuss the pharmacology of antihypertensive medications\nDiscuss herbal medications that are taken for common medical conditions\nDiscuss diagnosis and management of osteomyelitis\nDiscuss diagnosis and management of emergent pediatric conditions\nDiscuss diagnosis and management of food allergies in the pediatric population\nDiscuss diagnosis and treatment of eosinophilic esophagitis\nDiscuss screening tests and documentation required for Medicare visits\nDiscuss diagnosis and treatment modalities of acute and chronic urticaria\nDiscuss signs and symptoms of child abuse\nDiscuss family medicine cases seen in the office\nDiscuss symptoms and treatment of common vitamin toxicities\nDiscuss signs and symptoms of dental caries\nDiscuss red flag symptoms of pediatric neoplasms\nDiscuss symptoms and treatment of gender dysphoria\nDiscuss diagnosis and treatment of hyperbilirubinemia\nDiscuss symptoms and treatment of allergic rhinitis and viral illness\nDiscuss diagnosis and treatment of bromhidrosis\nDiscussing treatment modalities of HIV\nReview patient cases
URL:https://mecop.org/event/familyplus/
LOCATION:Live Course
CATEGORIES:AMA
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20260312T080000
DTEND;TZID=America/Chicago:20260312T170000
DTSTAMP:20260417T075624
CREATED:20260414T190108Z
LAST-MODIFIED:20260414T190113Z
UID:68163-1773302400-1773334800@mecop.org
SUMMARY:PediPlus
DESCRIPTION:
URL:https://mecop.org/event/pediplus-2/
LOCATION:Live
CATEGORIES:AMA
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20260312T080000
DTEND;TZID=America/Chicago:20260312T170000
DTSTAMP:20260417T075624
CREATED:20260414T192112Z
LAST-MODIFIED:20260414T192118Z
UID:68166-1773302400-1773334800@mecop.org
SUMMARY:PediPlus and FamilyPlus Presentation Prep
DESCRIPTION:See course agendas/objectives
URL:https://mecop.org/event/pediplus-and-familyplus-presentation-prep/
LOCATION:Internet Enduring Material
CATEGORIES:AMA
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20260312T170000
DTEND;TZID=America/Chicago:20260312T190000
DTSTAMP:20260417T075624
CREATED:20260310T194954Z
LAST-MODIFIED:20260409T143250Z
UID:67677-1773334800-1773342000@mecop.org
SUMMARY:MUSM Women in Medicine Annual Symposium
DESCRIPTION:Estrogen Processing and Breast Cancer Risk \nExplain why estrogen concentration alone poorly predicts breast cancer risk\nDescribe estrogen metabolic pathway bias (2-OH\, 4-OH\, 16-OH)\nRecognize the role of detox capacity\, inflammation\, and insulin signaling\nApply a systems framework for prevention and risk reduction \nCase-Based Reflections on Risk-Informed Breast Cancer Screening \nDescribe how breast density and family history influence individualized breast cancer risk assessment\nDiscuss when additional imaging beyond routine mammography may be appropriate\nApply formal risk assessment tools (e.g.\, Tyrer-Cuzick) to guide shared decision-making
URL:https://mecop.org/event/musm-women-in-medicine-annual-symposium/
LOCATION:Live Activity
CATEGORIES:AMA
END:VEVENT
END:VCALENDAR